Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 2.31% · OPTIONAL
· Pharmaceutical Preparations
RESEARCH SNAPSHOTLifevantage Corp's latest supported as-filed period reports revenue of $43.7M; gross margin moved 196 basis points lower on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 2.31% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 11.41% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value -25.20% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 42.05% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 79.02% · CORE
Level · gp.fundamentals.operating_margin
Raw value 3.84% · CORE
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed -44.4% from the comparable as-filed period.
Gross margin changed -196 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross profit changed -27.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
LFVN · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-342696SEC ↗8-KAug 3, 2026Period Jul 31, 20260001193125-26-330531SEC ↗4Jul 6, 2026Period Jul 1, 20260001193125-26-296262SEC ↗4Jul 6, 2026Period Jul 1, 20260001193125-26-296260SEC ↗4Jul 6, 2026Period Jul 1, 20260001193125-26-296258SEC ↗4Jun 17, 2026Period Jun 15, 20260001193125-26-274127SEC ↗4Jun 5, 2026Period Jun 3, 20260001193125-26-259533SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 0.46% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 1.60% · OPTIONAL
Inventory changed -17.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Net income changed -60.7% from the comparable as-filed period.
Operating income changed -58.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating margin changed -310 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-03-31. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001193125-26-208934